Brief: Marksans Pharma Gets US FDA Approval For Famotidine Tablets Usp, 10 Mg And 20 Mg
10/03/2023 06:11
March 10 (Reuters) - Marksans Pharma Ltd MARK.NS :
* GETS US FDA APPROVAL FOR FAMOTIDINE TABLETS USP, 10 MG AND
20 MG
Source text for Eikon: ID:nBSE3rRjxm
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg